| Male |
39 (66%) |
| Female |
20 (34%) |
| Age, median years (range) |
44 (27–70) |
| CD4+ T cell count at nadir, median cells/µl (range) |
250 (2–1200) |
| HIV-1 RNA load at nadir, median copies/ml (range) |
10∧5 (<50-10∧6) |
| Years since diagnosis, median years (range) |
4 (<1–28) |
| Treatment-naïve |
11 (19%), 32 blood samples |
| ART-experienced |
48 (81%), 163 blood samples |
| Years on ART, median years (range), n = 48 |
2.5 (<1–19) |
| Multidrug resistant HIV-1 infection (MDR) |
21 (36%), 85 blood samples |
| HCV, HBV, Syphilis, TBC co-infected |
23 (39%) |
